111 related articles for article (PubMed ID: 12604710)
1. Up-regulation of regulator of G protein signaling 4 expression in a model of neuropathic pain and insensitivity to morphine.
Garnier M; Zaratin PF; Ficalora G; Valente M; Fontanella L; Rhee MH; Blumer KJ; Scheideler MA
J Pharmacol Exp Ther; 2003 Mar; 304(3):1299-306. PubMed ID: 12604710
[TBL] [Abstract][Full Text] [Related]
2. Ultra-low-dose naloxone suppresses opioid tolerance, dependence and associated changes in mu opioid receptor-G protein coupling and Gbetagamma signaling.
Wang HY; Friedman E; Olmstead MC; Burns LH
Neuroscience; 2005; 135(1):247-61. PubMed ID: 16084657
[TBL] [Abstract][Full Text] [Related]
3. Regulator of G protein signaling 4 confers selectivity to specific G proteins to modulate mu- and delta-opioid receptor signaling.
Leontiadis LJ; Papakonstantinou MP; Georgoussi Z
Cell Signal; 2009 Jul; 21(7):1218-28. PubMed ID: 19324084
[TBL] [Abstract][Full Text] [Related]
4. Functional reduction in mu-opioidergic system in the spinal cord under a neuropathic pain-like state following chronic ethanol consumption in the rat.
Narita M; Miyoshi K; Narita M; Suzuki T
Neuroscience; 2007 Feb; 144(3):777-82. PubMed ID: 17156932
[TBL] [Abstract][Full Text] [Related]
5. Molecular mechanism of changes in the morphine-induced pharmacological actions under chronic pain-like state: suppression of dopaminergic transmission in the brain.
Narita M; Suzuki M; Imai S; Narita M; Ozaki S; Kishimoto Y; Oe K; Yajima Y; Yamazaki M; Suzuki T
Life Sci; 2004 Apr; 74(21):2655-73. PubMed ID: 15041447
[TBL] [Abstract][Full Text] [Related]
6. Effect of morphine on deep dorsal horn projection neurons depends on spinal GABAergic and glycinergic tone: implications for reduced opioid effect in neuropathic pain.
Chen YP; Chen SR; Pan HL
J Pharmacol Exp Ther; 2005 Nov; 315(2):696-703. PubMed ID: 16033910
[TBL] [Abstract][Full Text] [Related]
7. Characterization of chronic constriction of the saphenous nerve, a model of neuropathic pain in mice showing rapid molecular and electrophysiological changes.
Walczak JS; Pichette V; Leblond F; Desbiens K; Beaulieu P
J Neurosci Res; 2006 May; 83(7):1310-22. PubMed ID: 16511871
[TBL] [Abstract][Full Text] [Related]
8. Endogenous regulator of g protein signaling proteins reduce {mu}-opioid receptor desensitization and down-regulation and adenylyl cyclase tolerance in C6 cells.
Clark MJ; Traynor JR
J Pharmacol Exp Ther; 2005 Feb; 312(2):809-15. PubMed ID: 15383633
[TBL] [Abstract][Full Text] [Related]
9. Different effects of opioid and cannabinoid receptor agonists on C-fiber-induced extracellular signal-regulated kinase activation in dorsal horn neurons in normal and spinal nerve-ligated rats.
Kawasaki Y; Kohno T; Ji RR
J Pharmacol Exp Ther; 2006 Feb; 316(2):601-7. PubMed ID: 16221738
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of the regulator of G protein signalling RGS4 in the spinal cord decreases neuropathic hyperalgesia and restores cannabinoid CB1 receptor signalling.
Bosier B; Doyen PJ; Brolet A; Muccioli GG; Ahmed E; Desmet N; Hermans E; Deumens R
Br J Pharmacol; 2015 Nov; 172(22):5333-46. PubMed ID: 26478461
[TBL] [Abstract][Full Text] [Related]
11. Opioid peptide receptor studies. 17. Attenuation of chronic morphine effects after antisense oligodeoxynucleotide knock-down of RGS9 protein in cells expressing the cloned Mu opioid receptor.
Xu H; Wang X; Wang J; Rothman RB
Synapse; 2004 Jun; 52(3):209-17. PubMed ID: 15065220
[TBL] [Abstract][Full Text] [Related]
12. Depletion of capsaicin-sensitive afferents prevents lamina-dependent increases in spinal N-methyl-D-aspartate receptor subunit 1 expression and phosphorylation associated with thermal hyperalgesia in neuropathic rats.
Roh DH; Kim HW; Yoon SY; Seo HS; Kwon YB; Han HJ; Beitz AJ; Lee JH
Eur J Pain; 2008 Jul; 12(5):552-63. PubMed ID: 17933570
[TBL] [Abstract][Full Text] [Related]
13. Central glucocorticoid receptors regulate the upregulation of spinal cannabinoid-1 receptors after peripheral nerve injury in rats.
Wang S; Lim G; Mao J; Sung B; Yang L; Mao J
Pain; 2007 Sep; 131(1-2):96-105. PubMed ID: 17258396
[TBL] [Abstract][Full Text] [Related]
14. Differential galanin upregulation in dorsal root ganglia and spinal cord after graded single ligature nerve constriction of the rat sciatic nerve.
Coronel MF; Brumovsky PR; Hökfelt T; Villar MJ
J Chem Neuroanat; 2008 Jan; 35(1):94-100. PubMed ID: 17693056
[TBL] [Abstract][Full Text] [Related]
15. Endogenous regulator of G protein signaling proteins suppress Galphao-dependent, mu-opioid agonist-mediated adenylyl cyclase supersensitization.
Clark MJ; Neubig RR; Traynor JR
J Pharmacol Exp Ther; 2004 Jul; 310(1):215-22. PubMed ID: 15014136
[TBL] [Abstract][Full Text] [Related]
16. Loss of TRPV1-expressing sensory neurons reduces spinal mu opioid receptors but paradoxically potentiates opioid analgesia.
Chen SR; Pan HL
J Neurophysiol; 2006 May; 95(5):3086-96. PubMed ID: 16467418
[TBL] [Abstract][Full Text] [Related]
17. Involvement of neuropeptide Y in the acute, chronic and withdrawal responses of morphine in nociception in neuropathic rats: behavioral and neuroanatomical correlates.
Upadhya MA; Dandekar MP; Kokare DM; Singru PS; Subhedar NK
Neuropeptides; 2009 Aug; 43(4):303-14. PubMed ID: 19556004
[TBL] [Abstract][Full Text] [Related]
18. Contralateral neuropathic pain and neuropathology in dorsal root ganglion and spinal cord following hemilateral nerve injury in rats.
Hatashita S; Sekiguchi M; Kobayashi H; Konno S; Kikuchi S
Spine (Phila Pa 1976); 2008 May; 33(12):1344-51. PubMed ID: 18496347
[TBL] [Abstract][Full Text] [Related]
19. Expression of opioid receptors and c-fos in CB1 knockout mice exposed to neuropathic pain.
Pol O; Murtra P; Caracuel L; Valverde O; Puig MM; Maldonado R
Neuropharmacology; 2006 Jan; 50(1):123-32. PubMed ID: 16360182
[TBL] [Abstract][Full Text] [Related]
20. Evidence for a selective role of the delta-opioid agonist [8R-(4bS*,8aalpha,8abeta, 12bbeta)]7,10-Dimethyl-1-methoxy-11-(2-methylpropyl)oxycarbonyl 5,6,7,8,12,12b-hexahydro-(9H)-4,8-methanobenzofuro[3,2-e]pyrrolo[2,3-g]isoquinoline hydrochloride (SB-235863) in blocking hyperalgesia associated with inflammatory and neuropathic pain responses.
Petrillo P; Angelici O; Bingham S; Ficalora G; Garnier M; Zaratin PF; Petrone G; Pozzi O; Sbacchi M; Stean TO; Upton N; Dondio GM; Scheideler MA
J Pharmacol Exp Ther; 2003 Dec; 307(3):1079-89. PubMed ID: 14551288
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
